Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2016

01-01-2016 | Original Article

Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List

Authors: Nathalie H. Urrunaga, Laurence S. Magder, Matthew R. Weir, Don C. Rockey, Ayse L. Mindikoglu

Published in: Digestive Diseases and Sciences | Issue 1/2016

Login to get access

Abstract

Background and Aims

Although renal dysfunction is a known complication of acute liver failure (ALF), its frequency, severity, and impact among patients with ALF on the US liver transplant list are not well defined.

Methods

Organ Procurement and Transplantation data for ALF patients listed as status 1/1A from 2002 to 2012 were analyzed. The frequency and severity of renal dysfunction at the time of listing [the latter was categorized in 5 stages using estimated GFR (eGFR) according to Chronic Kidney Disease Epidemiology Collaboration creatinine 2009 equation] were determined and the association between renal dysfunction and waiting list mortality was assessed using Cox proportional hazard regression analysis.

Results

There were a total of 2280 adult patients with ALF, including 56 % with renal dysfunction (defined as eGFR < 60 ml/min/1.73 m2) at listing. The highest proportion of patients with renal dysfunction was among those with ALF caused by hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome, fatty liver disease of pregnancy, heat stroke/hyperthermia, hepatitis A virus, and drug-induced liver injury due to acetaminophen APAP, phenytoin, trimethoprim-sulfamethoxazole, and macrolides. Despite the fact that 69 % (468/674) of patients with APAP-induced ALF listed as status 1/1A had renal dysfunction, only 0.9 % underwent simultaneous liver-kidney transplantation. Six-week survival probabilities in patients with ALF on the liver transplant waiting list were 71, 59, 56, 59, and 42 % with renal dysfunction stages of 1, 2, 3, 4, and 5, respectively. Multivariate analysis showed that after controlling for age, etiology of ALF, INR, total bilirubin, and region, the relative risk of death increased progressively as eGFR declined (P < 0.0001).

Conclusions

Among patients with ALF on the liver transplant waiting list, renal dysfunction was common (overall prevalence of 56 %). Most importantly, severe renal dysfunction was associated with significantly increased mortality.
Literature
1.
go back to reference Lee WM, Stravitz RT, Larson AMCP. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology. 2011;55:965–967.CrossRef Lee WM, Stravitz RT, Larson AMCP. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology. 2011;55:965–967.CrossRef
2.
go back to reference Polson J, Lee WM. Disease AAftSoL. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179–1197.PubMedCrossRef Polson J, Lee WM. Disease AAftSoL. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179–1197.PubMedCrossRef
3.
go back to reference Czaja AJ, Freese DK. Disease AAftSoL. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36:479–497.PubMedCrossRef Czaja AJ, Freese DK. Disease AAftSoL. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36:479–497.PubMedCrossRef
4.
go back to reference Lee WC, Wu MJ, Cheng CH, et al. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. Am J Kidney Dis. 2001;38:1074–1081.PubMedCrossRef Lee WC, Wu MJ, Cheng CH, et al. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. Am J Kidney Dis. 2001;38:1074–1081.PubMedCrossRef
5.
go back to reference Peters DJ, Greene WH, Ruggiero F, et al. Herpes simplex-induced fulminant hepatitis in adults: a call for empiric therapy. Dig Dis Sci. 2000;45:2399–2404.PubMedCrossRef Peters DJ, Greene WH, Ruggiero F, et al. Herpes simplex-induced fulminant hepatitis in adults: a call for empiric therapy. Dig Dis Sci. 2000;45:2399–2404.PubMedCrossRef
6.
go back to reference Smilkstein MJ, Knapp GL, Kulig KW, et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med. 1988;319:1557–1562.PubMedCrossRef Smilkstein MJ, Knapp GL, Kulig KW, et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med. 1988;319:1557–1562.PubMedCrossRef
7.
go back to reference Ostapowicz G, Fontana RJ, Schiødt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947–954.PubMedCrossRef Ostapowicz G, Fontana RJ, Schiødt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947–954.PubMedCrossRef
8.
go back to reference O’Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–445.PubMed O’Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–445.PubMed
9.
go back to reference Belcher JM, Garcia-Tsao G, Sanyal AJ, et al. Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology. 2013;57:753–762.PubMedCrossRefPubMedCentral Belcher JM, Garcia-Tsao G, Sanyal AJ, et al. Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology. 2013;57:753–762.PubMedCrossRefPubMedCentral
10.
go back to reference Mindikoglu AL, Regev A, Seliger SL, et al. Gender disparity in liver transplant waiting-list mortality: the importance of kidney function. Liver Transpl. 2010;16:1147–1157.PubMedCrossRefPubMedCentral Mindikoglu AL, Regev A, Seliger SL, et al. Gender disparity in liver transplant waiting-list mortality: the importance of kidney function. Liver Transpl. 2010;16:1147–1157.PubMedCrossRefPubMedCentral
12.
go back to reference Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147.PubMedCrossRef Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147.PubMedCrossRef
13.
go back to reference SAS Activity-Based Management 6.3: User’s Guide. Cary, N.C.: SAS Institute, Inc.; 2007. SAS Activity-Based Management 6.3: User’s Guide. Cary, N.C.: SAS Institute, Inc.; 2007.
15.
go back to reference Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assn. 1958;53:457–481.CrossRef Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assn. 1958;53:457–481.CrossRef
16.
go back to reference Cox DR. Regression models and life-table. J R Stat Soc B. 1972;34:187–220. Cox DR. Regression models and life-table. J R Stat Soc B. 1972;34:187–220.
17.
go back to reference Wilkinson SP, Moodie H, Arroyo VA, et al. Frequency of renal impairment in paracetamol overdose compared with other causes of acute liver damage. J Clin Pathol. 1977;30:141–143.PubMedCrossRefPubMedCentral Wilkinson SP, Moodie H, Arroyo VA, et al. Frequency of renal impairment in paracetamol overdose compared with other causes of acute liver damage. J Clin Pathol. 1977;30:141–143.PubMedCrossRefPubMedCentral
18.
19.
go back to reference Tujios SR, Hynan LS, Vazquez MA, et al. Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol. 2015;13:352–359.PubMedCrossRef Tujios SR, Hynan LS, Vazquez MA, et al. Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol. 2015;13:352–359.PubMedCrossRef
20.
go back to reference Leithead JA, Ferguson JW, Bates CM, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut. 2009;58:443–449.PubMedCrossRef Leithead JA, Ferguson JW, Bates CM, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut. 2009;58:443–449.PubMedCrossRef
21.
go back to reference Ring-Larsen H, Palazzo U. Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis. Gut. 1981;22:585–591.PubMedCrossRefPubMedCentral Ring-Larsen H, Palazzo U. Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis. Gut. 1981;22:585–591.PubMedCrossRefPubMedCentral
23.
go back to reference Jin Q, Chen E, Jiang J, et al. Acute hepatic failure as a leading manifestation in exertional heat stroke. Case Rep Crit Care. 2012;2012:295867. Jin Q, Chen E, Jiang J, et al. Acute hepatic failure as a leading manifestation in exertional heat stroke. Case Rep Crit Care. 2012;2012:295867.
24.
go back to reference Yeo TP. Heat stroke: a comprehensive review. AACN Clin Issues. 2004;15:280–293.PubMed Yeo TP. Heat stroke: a comprehensive review. AACN Clin Issues. 2004;15:280–293.PubMed
25.
go back to reference Sibai BM, Ramadan MK, Usta I, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993;169:1000–1006.PubMedCrossRef Sibai BM, Ramadan MK, Usta I, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993;169:1000–1006.PubMedCrossRef
26.
go back to reference Castro MA, Fassett MJ, Reynolds TB, et al. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol. 1999;181:389–395.PubMedCrossRef Castro MA, Fassett MJ, Reynolds TB, et al. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol. 1999;181:389–395.PubMedCrossRef
27.
go back to reference Fesenmeier MF, Coppage KH, Lambers DS, et al. Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol. 2005;192:1416–1419.PubMedCrossRef Fesenmeier MF, Coppage KH, Lambers DS, et al. Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol. 2005;192:1416–1419.PubMedCrossRef
28.
go back to reference Rosenfeld J, Gura V, Boner G, et al. Interstitial nephritis with acute renal failure after erythromycin. Br Med J (Clin Res Ed). 1983;286:938–939.CrossRef Rosenfeld J, Gura V, Boner G, et al. Interstitial nephritis with acute renal failure after erythromycin. Br Med J (Clin Res Ed). 1983;286:938–939.CrossRef
29.
go back to reference Soni N, Harrington JW, Weiss R, et al. Recurrent acute interstitial nephritis induced by azithromycin. Pediatr Infect Dis J. 2004;23:965–966.PubMedCrossRef Soni N, Harrington JW, Weiss R, et al. Recurrent acute interstitial nephritis induced by azithromycin. Pediatr Infect Dis J. 2004;23:965–966.PubMedCrossRef
30.
go back to reference Tintillier M, Kirch L, Almpanis C, et al. Telithromycin-induced acute interstitial nephritis: a first case report. Am J Kidney Dis. 2004;44:e25–e27.PubMedCrossRef Tintillier M, Kirch L, Almpanis C, et al. Telithromycin-induced acute interstitial nephritis: a first case report. Am J Kidney Dis. 2004;44:e25–e27.PubMedCrossRef
31.
go back to reference Mansoor GA, Panner BJ, Ornt DB. Azithromycin-induced acute interstitial nephritis. Ann Intern Med. 1993;119:636–637.PubMedCrossRef Mansoor GA, Panner BJ, Ornt DB. Azithromycin-induced acute interstitial nephritis. Ann Intern Med. 1993;119:636–637.PubMedCrossRef
32.
go back to reference Mindikoglu AL, Magder LS, Regev A. Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database. Liver Transpl. 2009;15:719–729.PubMedCrossRef Mindikoglu AL, Magder LS, Regev A. Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database. Liver Transpl. 2009;15:719–729.PubMedCrossRef
33.
go back to reference Polman AJ, van der Werf TS, Tiebosch AT, et al. Early-onset phenytoin toxicity mimicking a renopulmonary syndrome. Eur Respir J. 1998;11:501–503.PubMedCrossRef Polman AJ, van der Werf TS, Tiebosch AT, et al. Early-onset phenytoin toxicity mimicking a renopulmonary syndrome. Eur Respir J. 1998;11:501–503.PubMedCrossRef
34.
go back to reference Hyman LR, Ballow M, Knieser MR. Diphenylhydantoin interstitial nephritis. Roles of cellular and humoral immunologic injury. J Pediatr. 1978;92:915–920.PubMedCrossRef Hyman LR, Ballow M, Knieser MR. Diphenylhydantoin interstitial nephritis. Roles of cellular and humoral immunologic injury. J Pediatr. 1978;92:915–920.PubMedCrossRef
35.
go back to reference Parry RG, Gordon P, Mason JC, et al. Phenytoin-associated vasculitis and ANCA positivity: a case report. Nephrol Dial Transpl. 1996;11:357–359.CrossRef Parry RG, Gordon P, Mason JC, et al. Phenytoin-associated vasculitis and ANCA positivity: a case report. Nephrol Dial Transpl. 1996;11:357–359.CrossRef
36.
go back to reference Michael JR, Mitch WE. Reversible renal failure and myositis caused by phenytoin hypersensitivity. JAMA. 1976;236:2773–2775.PubMedCrossRef Michael JR, Mitch WE. Reversible renal failure and myositis caused by phenytoin hypersensitivity. JAMA. 1976;236:2773–2775.PubMedCrossRef
37.
go back to reference Blakely P, McDonald BR. Acute renal failure due to acetaminophen ingestion: a case report and review of the literature. J Am Soc Nephrol. 1995;6:48–53.PubMed Blakely P, McDonald BR. Acute renal failure due to acetaminophen ingestion: a case report and review of the literature. J Am Soc Nephrol. 1995;6:48–53.PubMed
38.
go back to reference Leithead JA, Ferguson JW, Bates CM, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut. 2009;58:443–449.PubMedCrossRef Leithead JA, Ferguson JW, Bates CM, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut. 2009;58:443–449.PubMedCrossRef
39.
go back to reference O’Riordan A, Brummell Z, Sizer E, et al. Acute kidney injury in patients admitted to a liver intensive therapy unit with paracetamol-induced hepatotoxicity. Nephrol Dial Transplant. 2011;26:3501–3508.PubMedCrossRef O’Riordan A, Brummell Z, Sizer E, et al. Acute kidney injury in patients admitted to a liver intensive therapy unit with paracetamol-induced hepatotoxicity. Nephrol Dial Transplant. 2011;26:3501–3508.PubMedCrossRef
40.
go back to reference Lines SW, Wood A, Bellamy MC, et al. The outcomes of critically ill patients with combined severe acute liver and kidney injury secondary to paracetamol toxicity requiring renal replacement therapy. Ren Fail. 2011;33:785–788.PubMedCrossRef Lines SW, Wood A, Bellamy MC, et al. The outcomes of critically ill patients with combined severe acute liver and kidney injury secondary to paracetamol toxicity requiring renal replacement therapy. Ren Fail. 2011;33:785–788.PubMedCrossRef
41.
go back to reference Fan PC, Chen YC, Tian YC, et al. Acute renal failure associated with acute non-fulminant hepatitis A: a case report and review of literature. Ren Fail. 2009;31:756–764.PubMedCrossRef Fan PC, Chen YC, Tian YC, et al. Acute renal failure associated with acute non-fulminant hepatitis A: a case report and review of literature. Ren Fail. 2009;31:756–764.PubMedCrossRef
42.
go back to reference Kim HW, Yu MH, Lee JH, et al. Experiences with acute kidney injury complicating non-fulminant hepatitis A. Nephrology (Carlton). 2008;13:451–458.CrossRef Kim HW, Yu MH, Lee JH, et al. Experiences with acute kidney injury complicating non-fulminant hepatitis A. Nephrology (Carlton). 2008;13:451–458.CrossRef
43.
go back to reference Pal RB, Saha P, Das I, et al. Fulminant hepatitis and glomerulonephritis—a rare presentation of hepatitis A virus infection. Acta Paediatr. 2011;100:e132–e134.PubMedCrossRef Pal RB, Saha P, Das I, et al. Fulminant hepatitis and glomerulonephritis—a rare presentation of hepatitis A virus infection. Acta Paediatr. 2011;100:e132–e134.PubMedCrossRef
44.
go back to reference McCann UG 2nd, Rabito F, Shah M, et al. Acute renal failure complicating nonfulminant hepatitis A. West J Med. 1996;165:308–310.PubMedPubMedCentral McCann UG 2nd, Rabito F, Shah M, et al. Acute renal failure complicating nonfulminant hepatitis A. West J Med. 1996;165:308–310.PubMedPubMedCentral
45.
go back to reference Jung YJ, Kim W, Jeong JB, et al. Clinical features of acute renal failure associated with hepatitis A virus infection. J Viral Hepat. 2010;17:611–617.PubMed Jung YJ, Kim W, Jeong JB, et al. Clinical features of acute renal failure associated with hepatitis A virus infection. J Viral Hepat. 2010;17:611–617.PubMed
46.
go back to reference Watanabe S, Nomoto H, Matsuda M, et al. A case of acute renal failure associated with type A acute hepatitis responds dramatically to plasmapheresis. Tokai J Exp Clin Med. 1986;11:1–4.PubMed Watanabe S, Nomoto H, Matsuda M, et al. A case of acute renal failure associated with type A acute hepatitis responds dramatically to plasmapheresis. Tokai J Exp Clin Med. 1986;11:1–4.PubMed
47.
go back to reference Zikos D, Grewal KS, Craig K, et al. Nephrotic syndrome and acute renal failure associated with hepatitis A virus infection. Am J Gastroenterol. 1995;90:295–298.PubMed Zikos D, Grewal KS, Craig K, et al. Nephrotic syndrome and acute renal failure associated with hepatitis A virus infection. Am J Gastroenterol. 1995;90:295–298.PubMed
48.
go back to reference Evans JT, Shepard MM, Oates JC, et al. Rituximab-responsive cryoglobulinemic glomerulonephritis in a patient with autoimmune hepatitis. J Clin Gastroenterol. 2008;42:862–863.PubMedCrossRef Evans JT, Shepard MM, Oates JC, et al. Rituximab-responsive cryoglobulinemic glomerulonephritis in a patient with autoimmune hepatitis. J Clin Gastroenterol. 2008;42:862–863.PubMedCrossRef
49.
go back to reference Section 2: AKI definition. Kidney Int Suppl. 2012;2:19–36. Section 2: AKI definition. Kidney Int Suppl. 2012;2:19–36.
Metadata
Title
Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List
Authors
Nathalie H. Urrunaga
Laurence S. Magder
Matthew R. Weir
Don C. Rockey
Ayse L. Mindikoglu
Publication date
01-01-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3870-y

Other articles of this Issue 1/2016

Digestive Diseases and Sciences 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.